A covered stent for improving blood flow rate and characterization method
By combining the bioabsorbable stent and elastic film on the bioabsorbable stent, the texture structure and through-hole design of the film are used to solve the problems of thrombosis and blood flow resistance, and the promotion of blood flow velocity and vascular recovery is achieved.
Patent Information
- Application Number
- CN202210886384.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-07-26
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2042-07-26
AI Technical Summary
After the existing bioabsorbable stent is implanted in the blood vessel, it is easy to cause thrombosis and blood flow resistance, affect blood flow velocity, and its absorption cycle is prolonged, affecting endothelialization and vascular recovery.
A degradable stent is used to combine an elastic film. The inner side wall of the film is equipped with textured structure and regular distribution through holes. It is elastically attached to the stent, which reduces blood impact, promotes endothelialization, and optimizes blood flow through finite element analysis.
Effectively avoid thrombosis, reduce the risk of restenosis, increase blood flow rate, shorten the endothelialization cycle, promote vascular recovery, and improve the success rate of surgery.
Smart Images

Figure CN115252215B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of medical devices, and in particular to a coated stent for improving blood flow rate and a characterization method thereof. Background Art
[0002] In recent years, cardiovascular disease has become the number one killer endangering human health. Relevant statistics show that the number of people suffering from cardiovascular disease in my country is about 330 million, and it is on an increasing trend year by year. The main cause of cardiovascular disease is the accumulation of fat inside the blood vessels, which causes the narrowing of the blood vessels, and then the blood cannot flow to the brain or heart in time, threatening human life safety. Generally, cardiovascular diseases can be divided into neural, coronary and peripheral according to the distribution of blood vessels. At present, the treatment of cardiovascular diseases mainly relies on drugs and device therapy, and device therapy is a more commonly used method. Among them, device therapy can be divided into three methods: percutaneous transluminal coronary angioplasty (PTCA), bare metal stent (BMS), drug eluting stent (DES). The DES in the above method includes metal stents and bioresorbable vascular stents (Bioresorbable Vascular Stent, BVS). The existing bioresorbable stents are generally composed of annular wave rings, connecting rods and developing point holes. However, when this type of stent enters the blood vessel, the stent rod will always protrude on the inner wall of the blood vessel. When blood flows through, it will impact the stent rod, causing a large amount of platelets to accumulate here, which can easily cause thrombosis in the stent.
[0003] In order to reduce the occurrence of the above-mentioned problems, some coated stents have emerged, such as the coated stent provided by Publication No. CN114569300A and the coated stent provided by Publication No. CN114366390A, which can be fixed on the stent by sewing, bonding, hot melting, etc. This coating process is feasible for bare metal stents, but it will cause damage to bioresorbable stents, especially affecting the strength of the stent, which may cause the stent to break during use, posing a danger to the patient.
[0004] At the same time, although the covered stent can effectively inhibit the formation of blood clots, the implanted stent needs to complete rapid endothelialization with the inner wall of the blood vessel to reduce the probability of vascular restenosis. Because the absorbable elastic film covers the inner wall of the blood vessel as a whole, and its absorption requires a certain period of time, these two points will prolong the endothelialization period, which is not conducive to patient recovery. The main reason for the slowdown in blood flow is vascular stenosis, which is a structural cause. Although the patency of blood vessels can be significantly improved after stent treatment, the resistance to blood flow cannot be ignored. It is another reason that affects the slowdown in blood flow, and the existing covered stents cannot effectively solve the problem of blood flow resistance. Summary of the invention
[0005] The purpose of the present invention is to solve the shortcomings of the prior art and to propose a covered stent and a characterization method for improving blood flow rate.
[0006] In order to achieve the above-mentioned purpose, the present invention adopts the following technical solution: a covered stent for improving blood flow rate, comprising:
[0007] A degradable stent body;
[0008] An elastic film, wherein the inner side wall of the elastic film is a textured structure;
[0009] The outer side wall of the elastic film is attached to the inner side wall of the degradable stent body, so that the elastic film and the stent body form a whole;
[0010] The surface of the elastic film is provided with regularly distributed through holes for the attachment and growth of blood vessel endothelial cells.
[0011] As a further description of the above technical solution, the stent is formed by laser cutting, and the outer surface of the stent is sprayed with anti-proliferative drugs.
[0012] As a further description of the above technical solution, the elastic film is a degradable material, and its material is any one of polydioxanone, poly(glycolide caprolactone), poly(glycolide trimethylene carbonate), polyglycolide, and poly(glycolide L-lactide).
[0013] As a further description of the above technical solution, the inner side wall of the elastic film is provided with a plurality of protrusions along the length direction, and the protrusions are arranged around the inner side wall.
[0014] As a further description of the above technical solution, the shape of the through holes is any one of circular, square, triangular or rhombus, and the through holes are strip-shaped or staggered on the elastic film.
[0015] As a further description of the above technical solution, the elastic film is formed by injection molding or blow molding.
[0016] As a further description of the above technical solution, the length of the elastic film is greater than the length of the bracket, and the outer diameter of the elastic film is not less than the inner diameter of the bracket.
[0017] As a further description of the above technical solution, the length between the two end boundaries of the through hole distribution is slightly greater than the length of the bracket.
[0018] As a further description of the above technical solution, the shape of the texture structure is any one of circular, square, triangular or diamond.
[0019] A method for characterizing the performance of a stent graft, comprising:
[0020] Finite element analysis model establishment: based on the vascular model, the blood fluid domain is simplified. The length of the simulation model is the length of the stent graft, and the diameter is the diameter of the stent graft after expansion. The finite element analysis model of the textured fluid domain and the finite element analysis model of the non-textured fluid domain are established through three-dimensional modeling software.
[0021] Mesh model construction, dividing the finite element analysis model of the textured fluid domain and the finite element analysis model of the non-textured fluid domain into structured tetrahedral meshes;
[0022] Solver selection, judging the flow state of blood in blood vessels based on the Reynolds number;
[0023]
[0024] Where Re is the Reynolds number; ρ is the density of blood, in kg / m 3 ; u is the blood flow velocity, unit is m / s; l is the characteristic size, unit is m; μ is the dynamic viscosity of blood, unit is pa·s. According to the calculation results, it is found that Re<2000, so the flow state of blood in the blood vessel is laminar flow, and the laminar solver is selected;
[0025] Material assignment, set the material parameters of blood to: density 1.05*10 -3 kg / m 3 : Dynamic viscosity 4.0Mpa / s;
[0026] The boundary conditions were determined, and the blood velocity was determined to be 0.064 m / s;
[0027] Iterative solution calculation, the data is obtained through the mathematical equation model built into the simulation software;
[0028] After post-processing, after the iterative calculation is completed, a plane is established in the middle part of the fluid domain, and a velocity distribution cloud map is created based on the established plane.
[0029] The present invention has the following beneficial effects:
[0030] 1. The stent in the present invention has absorbable properties, and the elastic film also has absorbable properties, wherein the outer diameter of the elastic film is greater than or equal to the inner diameter of the stent. Because the film is elastic, it can be attached to the stent by its own elastic action, on the one hand, providing auxiliary support to the stent, and on the other hand, avoiding direct contact between the stent rod and the blood, reducing the impact of blood on the stent rod, thereby preventing acute thrombosis caused by platelet accumulation. At the same time, the elastic film does not need to be fixed to the stent by sewing, bonding, hot melting, etc., but can be fixed to the BVS only by relying on its own elasticity, effectively avoiding damage to the BVS.
[0031] 2. The present invention has regularly distributed through holes on the film. Under the joint action of the through holes and the elastic film, it not only improves the speed of endothelialization of the inner wall of the blood vessel and the stent, but also effectively avoids the formation of acute thrombosis, reduces the risk of postoperative restenosis, reduces patient pain, and improves the success rate of surgery.
[0032] 3. The present invention can effectively reduce the flow resistance of blood in the elastic film by setting a texture structure on the inner wall of the elastic film, thereby increasing the blood flow rate, promoting the recovery of blood vessels after surgery, and greatly improving the patient's physiological state. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] Figure 1 A schematic diagram of a covered stent for improving blood flow rate proposed by the present invention;
[0034] Figure 2 A front view of a stent graft for improving blood flow rate proposed by the present invention;
[0035] Figure 3 This is a schematic diagram of an injection molding mold for an elastic film in a stent graft for improving blood flow rate proposed by the present invention;
[0036] Figure 4 This is a schematic diagram of a blow molding mold for an elastic film in a stent graft for improving blood flow rate proposed by the present invention;
[0037] Figure 5 A schematic diagram of the cell growth direction in a coated stent for improving blood flow rate proposed by the present invention;
[0038] Figure 6 A schematic diagram of a performance characterization method for a stent graft proposed in the present invention;
[0039] Figure 7 This is a velocity distribution cloud diagram of the non-textured elastic film proposed by the present invention;
[0040] Figure 8The velocity distribution cloud diagram of the textured elastic film proposed by the present invention;
[0041] Fig. 9 This is a comparison diagram of the center line velocity distribution of the non-textured elastic film and the textured elastic film proposed in the present invention.
[0042] Legend:
[0043] 1. Bracket body; 2. Elastic film; 3. Texture structure; 31. Protrusion; 4. Through hole; 51. Inner mold; 52. Outer mold; 61. Left mold; 62. Right mold. DETAILED DESCRIPTION
[0044] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0045] Reference Figure 1-2 An embodiment of the present invention is as follows: a coated stent for improving blood flow rate, comprising a degradable stent body 1. The material of the stent body 1 may be polylactic acid. The stent body 1 mainly comprises a plurality of annular wavy circles, a connecting rod and developing point holes arranged on the annular wavy circles. The annular wavy circles are distributed along the axial direction of the stent body. The annular wavy circles mainly play the role of supporting blood vessels, and the connecting rod mainly connects and fixes the plurality of annular wavy circles. The developing point holes mainly install platinum developing points therein to play the role of developing in the blood vessels.
[0046] In some embodiments, the outer surface of the stent body 1 may be sprayed with anti-proliferative drugs, such as rapamycin and paclitaxel, or other anti-proliferative drugs.
[0047] Reference Figure 1 The inner wall of the elastic film 2 is a texture structure 3. Specifically, the inner wall of the elastic film 2 is provided with a plurality of protrusions along the length direction, and the protrusions are arranged around the inner wall, wherein the shape of the protrusions, i.e., the shape of the texture structure 3, is any one of circular, square, triangular or diamond, but is not limited to the above structure, and different structures can be set according to actual needs, and the diameter of the protrusions in the texture structure 3 is between 100μm-150μm, and the height is between 10-50μm. By providing a texture structure on the inner wall of the elastic film 2, the blood flow resistance can be reduced, thereby increasing the blood flow rate.
[0048] The outer wall of the elastic film 2 is provided with a plurality of regularly distributed through holes 4, the through holes 4 are very small, and the size thereof is between 100 μm and 150 μm. The plurality of through holes 4 provided on the outer wall of the elastic film 2 is used to facilitate the rapid growth of vascular cells, such as Figure 5 As shown, the two ports and through hole 4 on the elastic film 2 can allow the stent and the blood vessel inner wall cells to undergo endothelialization, which can accelerate the speed of endothelialization of the stent and the blood vessel inner wall cells compared to the traditional method of slowly growing from the two ports of the elastic film 2 to the middle.
[0049] The outer wall of the elastic film 2 is attached to the inner wall of the degradable stent body 1, so that the elastic film 2 and the stent body 3 form a whole, wherein the outer diameter of the elastic film 2 is not less than the inner diameter of the stent body 1. After the stent body 1 and the elastic film 2 are formed, the stent body 1 and the elastic film 2 are pressed onto the balloon by a pressing device, so that the diameter of the stent body 1 is reduced to about 30% of the original. At this time, the size of the stent body is smaller, which is convenient for the delivery system to deliver it to the patient's diseased area. After reaching the diseased area, the outer diameter of the stent is expanded to about 80% of the initial diameter through balloon filling. Due to the elasticity of the elastic film 2, it can be tightly attached to the inner wall of the stent body 1 and the inner wall of the blood vessel without the help of external force. Compared with fixing it on the stent body 1 by sewing, bonding and hot melting, it will not cause damage to the stent body 1.
[0050] The material of the elastic film 2 can be any one of polydioxanone, poly(glycolide caprolactone), poly(glycolide trimethylene carbonate), polyglycolide, and poly(glycolide L-lactide), and the surface of the elastic film 2 can also be coated with heparin, and the amount of heparin is controlled to be 100-500 μg / mm 2 Heparin can be released completely in the blood vessel within 10 days. The elastic film 2 with heparin can play an anticoagulant role and prevent the formation of thrombus in the stent.
[0051] In some embodiments, the stent body 1 is formed by laser cutting, and the elastic film 2 is formed by injection molding. Figure 3 , which is a mold for injection molding of the elastic film 2. The mold consists of an inner mold 61 and an outer mold 62, wherein the outer mold 62 is a detachable structure, thereby facilitating demoulding. The outer surface of the inner mold 61 is provided with a plurality of protruding structures, the diameter of the protruding structures is between 100 and 150 μm, and the height is 10 to 50 μm. The gap between the inner mold 61 and the outer mold 62 is 10-25 μm, so the wall thickness of the elastic film 2 after molding is also 10-25 μm. In the actual molding process, the raw material of the elastic film 2 in a molten state is injected into the mold. After cooling, the outer mold 62 is opened to obtain the elastic film 2 with a surface texture on the inner side.
[0052] In some embodiments, the elastic film 2 is formed by blow molding. Specifically, the blow molding mold is as follows: Figure 4 As shown, the mold consists of a right mold 62 and a left mold 61, and the two are detachable structures, which are convenient for demolding the elastic film 2 after blow molding. The diameter of the pit of the blow molding mold is usually between 100 and 150 μm, the depth is 10 to 50 μm, and the wall thickness is 10 to 25 μm. The wall thickness of the elastic film 2 is controlled by the temperature and pressure during blow molding. During actual molding, the elastic film tube blank is placed in the mold for blow molding. After cooling, the outer mold is opened to obtain an elastic film 2 with a surface texture on the outside, and then the elastic film 2 is reversed and sewn to obtain an elastic film 2 with a surface texture on the inside.
[0053] In some embodiments, the micro-through holes 4 on the surface of the elastic film 2 are formed by a metal plate with spikes, wherein the shape, size and distribution of the spikes are consistent with the through holes 4 on the elastic film 2. After the elastic film 2 is rolled on the through hole mold for one circle, the micro-through holes can be processed, wherein the shape of the through holes 4 is any one of circular, square, triangular or diamond, or other regular shapes, and the through holes 4 are strip-shaped or staggered on the elastic film 2.
[0054] After the elastic film 2 is formed and the through holes on the surface are formed, the elastic film 2 needs to be sewn together, wherein the sewing method can be hot melt welding, hot air welding, laser welding, etc.
[0055] Reference Figure 6 An embodiment of the present invention provides a method for characterizing the performance of a stent graft, comprising:
[0056] The establishment of the finite element analysis model, in this simulation, is to simulate the flow of blood in the blood vessel. According to the blood vessel model, the blood fluid domain is simplified. In the present invention, since the length of the vascular lesion area is shorter than the length of the stent graft, the length of the stent graft is used as the length of the simulation model, and the diameter is the diameter of the stent after expansion. Then, a finite element analysis model is established through three-dimensional modeling software, such as UG, Solidworks or Pro-E, which are a textured fluid domain and a non-textured fluid domain respectively;
[0057] The grid model is constructed by dividing the model of the textured fluid domain and the model of the non-textured fluid domain into structured tetrahedral grids, and one end face is named as the blood flow inlet, the other end face is named as the blood flow outlet, and the outer surface is the wall;
[0058] Solver selection, judging the flow state of blood in blood vessels based on the Reynolds number.
[0059]
[0060] Where ρ is the density of blood, in kg / m 3 ; u is the flow velocity of blood, unit is m / s; l is the characteristic size, unit is m; μ is the dynamic viscosity of blood, unit is pa·s.
[0061] According to the calculation results, it is found that Re is less than 2000, so the flow state of blood in the blood vessels is laminar flow, and the laminar solver is selected.
[0062] Material assignment, because there are many elements in the blood, and 40-50% of them are cellular components, including red blood cells, white blood cells, platelets, etc., and the non-cellular components in the blood are plasma and serum, in addition to the above, it also includes water, electrolytes, proteins and other inorganic and organic substances. At the same time, since the blood parameters of men and women are the same and fluctuate within a certain range, so on the basis of not affecting the accuracy of the calculation, for the convenience of calculation, the material parameters of blood are set as: density 1.05*10 - 3 kg / m 3 , dynamic viscosity 4.0Mpa / s;
[0063] The boundary conditions were determined. The main parameter was the blood inlet velocity, which was determined to be 0.064 m / s.
[0064] Iterative solution calculation, the data is obtained through the mathematical equation model built into the simulation software;
[0065] After the iterative calculation is completed, a plane is first established in the middle of the fluid domain, and then a velocity distribution cloud map is created based on the established plane, such as Figure 7 , Figure 8 As shown. Figure 7 and Figure 8 Analysis shows that the maximum blood flow rate of the elastic film with texture is 0.124m / s, while the maximum blood flow rate of the elastic film without texture is 0.117m / s. This is mainly because the existence of surface texture effectively reduces the resistance of blood flow, thereby increasing the blood flow rate in the blood vessels.
[0066] Take the center line of the plane and analyze the blood flow velocity under the two elastic films based on the center line. Fig. 9 .according to Fig. 9 The analysis found that under the textured elastic film, the blood flow rate is almost completely greater than that under the non-textured elastic film, which is consistent with the results obtained from the velocity cloud map. Therefore, it can be concluded that under the same blood environmental conditions and the same elastic film parameters, the blood flow rate in the textured elastic film is significantly improved compared to the blood flow rate in the non-textured elastic film.
[0067] Finally, it should be noted that the above is only a preferred embodiment of the present invention and is not intended to limit the present invention. Although the present invention has been described in detail with reference to the aforementioned embodiments, it is still possible for those skilled in the art to modify the technical solutions described in the aforementioned embodiments or to make equivalent substitutions for some of the technical features therein. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A covered stent for improving blood flow velocity, characterized in that: include: A degradable stent body; An elastic film, wherein the inner side wall of the elastic film is a texture structure, wherein the texture structure is a plurality of protrusions arranged along the length direction of the inner side wall of the elastic film, wherein the protrusions are arranged around the inner side wall, and wherein the texture structure is used to reduce resistance during blood flow, wherein the diameter of the protrusions in the texture structure is 100 μm-150 μm, and the height is 10-50 μm; The elastic film relies on its own elasticity to make its outer wall adhere to the inner wall of the degradable stent body, so that the elastic film and the stent body form a whole, and the elastic film can reduce damage to the stent body; The surface of the elastic film is provided with regularly distributed through holes for the attachment and growth of blood vessel endothelial cells.
2. The stent graft for improving blood flow rate according to claim 1, characterized in that: The stent is formed by laser cutting, and the outer surface of the stent is sprayed with anti-proliferation drugs.
3. The stent graft for improving blood flow rate according to claim 1, characterized in that: The elastic film is a degradable material, and the material is any one of polydioxanone, poly(glycolide caprolactone), poly(glycolide trimethylene carbonate), polyglycolide, and poly(glycolide L-lactide).
4. The stent graft for improving blood flow rate according to claim 1, characterized in that: The through holes are in any one of a circular, square, triangular or rhombus shape, and the through holes are in a strip shape or staggered distribution on the elastic film.
5. The stent graft for improving blood flow rate according to claim 1, characterized in that: The elastic film is formed by injection molding or blow molding.
6. The stent graft for improving blood flow rate according to claim 1, characterized in that: The length of the elastic film is greater than the length of the bracket, and the outer diameter of the elastic film is not less than the inner diameter of the bracket.
7. The stent graft for improving blood flow rate according to claim 1, characterized in that: The length between the two end boundaries of the through-hole distribution is slightly greater than the length of the bracket.
8. The stent graft for improving blood flow rate according to claim 1, characterized in that: The texture structure has a shape of any one of circle, square, triangle or rhombus.
